Metabolic and hemodynamic effects of sodium-dependent glucose cotransporter 2 inhibitors on cardio-renal protection in the treatment of patients with type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Metabolic and hemodynamic effects of sodium-dependent glucose cotransporter 2 inhibitors on cardio-renal protection in the treatment of patients with type 2 diabetes mellitus

Published:2017-05-12 Issue:4 Volume:8 Page:416-427
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Investig

Author:

Kashiwagi Atsunori¹,Maegawa Hiroshi²

Affiliation:

1. Kusatsu General Hospital; Kusatsu Japan

2. Department of Medicine; Shiga University of Medical Science; Otsu Shiga Japan

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdi.12644/fullpdf

Reference102 articles.

1. The human kidney low affinity Na+/glucose cotransporter SGLT2, Delineation of the major renal reabsorptive mechanism for D-glucose;Kanai;J Clin Invest,1994

2. Biology of human sodium glucose transporters;Wright;Physiol Rev,2011

3. The high affinity Na+/glucose cotransporter;Lee;J Biol Chem,1994

4. Renal glucose reabsorption inhibitors to treat diabetes;Bailey;Trends Pharmacol Sci,2011

5. Novel hypothesis to explain why SGLT2 inhibitors inhibit only 30-50% of filtered glucose load in humans;Abdul-Ghani;Diabetes,2013

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Renoprotective Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i)—A Narrative Review;International Journal of Molecular Sciences;2024-06-27

2. Enzalutamide: Understanding and Managing Drug Interactions to Improve Patient Safety and Drug Efficacy;Drug Safety;2024-04-12

3. Renoprotective strategies;World Journal of Nephrology;2024-03-25

4. Changes in serum levels of liver-related parameters, uric acid, and hemoglobin in patients with type 2 diabetes mellitus under treatment with tofogliflozin—a post-hoc analysis of the UTOPIA study;Diabetology International;2024-02-10

5. Primordial Drivers of Diabetes Heart Disease: Comprehensive Insights into Insulin Resistance;Diabetes & Metabolism Journal;2024-01-31